Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Other Non-Current Assets (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Other Non-Current Assets for 4 consecutive years, with $243000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 252.17% to $243000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $243000.0, a 252.17% increase, with the full-year FY2025 number at $243000.0, up 252.17% from a year prior.
  • Other Non-Current Assets was $243000.0 for Q4 2025 at Spruce Biosciences, up from $62000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $674000.0 in Q2 2022 to a low of $62000.0 in Q3 2025.
  • A 4-year average of $391812.5 and a median of $528000.0 in 2023 define the central range for Other Non-Current Assets.
  • Biggest YoY gain for Other Non-Current Assets was 252.17% in 2025; the steepest drop was 88.32% in 2025.
  • Spruce Biosciences' Other Non-Current Assets stood at $640000.0 in 2022, then dropped by 9.06% to $582000.0 in 2023, then plummeted by 88.14% to $69000.0 in 2024, then surged by 252.17% to $243000.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Other Non-Current Assets are $243000.0 (Q4 2025), $62000.0 (Q3 2025), and $64000.0 (Q2 2025).